CytoPherx was founded in July 2007 and is headquartered in Ann Arbor, Michigan. It is a venture backed, clinical stage medical device company addressing inflammation-based diseases and conditions. The company's products are custom configurations of a proprietary selective cytopheresis-based inflammation modulating system.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/04/12 | $34,000,000 |
Capital Midwest Fund Early Stage Partners ONSET Ventures | undisclosed |
